Alankit raises ₹43 crore via warrants allotment in 2026

What Alankit approved on October 5

Alankit Limited approved the preferential allotment of 5 crore fully convertible warrants to its promoter, Alka Agarwal. The decision was taken by the Management Committee of the Board of Directors at its meeting held on October 5, 2026. The company disclosed an aggregate fundraising of ₹43 crore for this tranche. The warrants have been issued on a preferential basis to an allottee classified under the Promoter and Promoter Group category. The announcement is part of a broader warrant issuance plan that the company had placed before shareholders earlier in the year. The allotment also follows prior board and shareholder approvals for a larger quantum of warrants.

Key terms: 5 crore warrants priced at ₹8.60

The issue price has been fixed at ₹8.60 per warrant. Alankit stated the total issue size for this allotment as ₹43,00,00,000, which is ₹43 crore. Each warrant carries the right to subscribe to one equity share of face value ₹1 each. The warrants are convertible at the option of the holder, in one or more tranches. The maximum conversion window is 18 months from the date of allotment, as described in the company’s disclosures around the preferential issue. The company also noted the payment structure typically applicable to such warrants, where at least 25% of the issue price is paid at allotment and the balance 75% is payable upon exercise.

Who received the warrants and under which category

The warrants have been allotted to Alka Agarwal. The company classified the allottee under the Promoter Group category. This classification matters because preferential issuances to promoters are closely tracked for changes in control, capital allocation, and dilution dynamics. In the AGM material related to the broader issuance, Alankit had listed promoter and public category allottees separately. For this specific October 5 allotment, the company’s disclosure clearly states that the issuance is to a member of the Promoter and Promoter Group category.

How this fits into the ₹86 crore warrant plan

Alankit’s board had earlier approved a preferential issue of up to 10 crore fully convertible warrants at ₹8.60 each, aggregating up to ₹86 crore in cash. That board approval was taken at a meeting held on August 7, 2026, subject to shareholder and regulatory approvals. Shareholders subsequently approved the issuance of up to 10,00,00,000 fully convertible warrants at the company’s 37th Annual General Meeting held on September 8, 2026. The October 5 allotment of 5 crore warrants represents half of the 10 crore warrant proposal. The earlier disclosures also included a second proposed allottee for the remaining 5 crore warrants under the public category, Ramesh Sawalram Saraogi, within the overall 10 crore structure.

Use of proceeds: investment in ATL and corporate purposes

From the proposed ₹86 crore proceeds of the full preferential issue, Alankit earmarked ₹70 crore for investment in its wholly owned subsidiary, Alankit Technologies Limited (ATL). The remaining ₹16 crore was earmarked for general corporate purposes. The company stated that the funds intended for ATL are to strengthen its capital base and meet the applicable net-worth requirement of ₹75 crore prescribed under SEBI (Custodian) Regulations, 1996. This is linked to ATL’s proposed application for registration as a Custodian. The utilisation timeline provided by the company for these objects extends up to August 31, 2028.

Capital and dilution: what the company disclosed

Alankit disclosed that consequent to the October 5 allotment, the paid-up equity share capital of the company on a fully diluted basis will stand at ₹32,11,58,100, which is about ₹32.12 crore. Separately, the company stated earlier that upon full conversion of all warrants under the broader 10 crore proposal, the post-preferential share capital on a fully diluted basis would be ₹37,11,58,100, or about ₹37.12 crore. These figures are important because warrants convert into equity shares and can change the fully diluted share base over time. The AGM disclosures also included expected shifts in promoter and public shareholding upon full conversion of warrants.

Regulatory and approval trail behind the issue

The board had sought member approval by special resolution under Sections 42 and 62(1)(c) of the Companies Act, 2013 and Regulation 160 of SEBI (ICDR) Regulations, 2018, as cited in the company’s AGM-related disclosures. Alankit also referenced the preferential issuance process through exchange-related stages, including an “In-Principle” stage entry for the company. Preferential allotments and warrant issuances typically involve exchange and regulatory compliances, as well as pricing and lock-in related provisions, depending on applicable rules. The company’s disclosures focused on the approvals and structure, including who the allottees are and how proceeds are intended to be used.

Timeline of events leading to the allotment

Key facts from the company’s disclosure

Market impact: what investors typically track here

The disclosures do not include any stock price move or trading impact, so the immediate market reaction cannot be quantified from the provided information. Still, investors generally track preferential warrant allotments for three practical reasons: the inflow of funds (₹43 crore in this tranche), the stated use of proceeds (part of a plan where ₹70 crore was earmarked for ATL and ₹16 crore for general corporate purposes), and potential dilution upon conversion. The payment structure also matters because only part of the total proceeds may come in at allotment, with the remainder received when warrants are exercised. Since the conversion window extends up to 18 months from allotment, the timing of equity issuance can be staggered. The company’s fully diluted capital figures provide a reference for how the equity base may expand as conversions occur.

Why this development matters

This allotment is a concrete step in executing a larger capital-raising plan approved through board and shareholder routes in 2026. It also ties directly to the company’s stated plan to fund capital requirements at its wholly owned subsidiary, Alankit Technologies Limited, in connection with a proposed custodian registration process. For shareholders, the key takeaway is that the preferential issuance is moving from approval stage to actual allotment stage, starting with the promoter-group allocation of 5 crore warrants. The remaining part of the 10 crore proposal, including warrants proposed for a public-category investor, remains part of the broader structure described in the company’s AGM materials.

Conclusion

Alankit’s allotment of 5 crore fully convertible warrants to promoter Alka Agarwal at ₹8.60 each raises ₹43 crore and marks progress on the company’s ₹86 crore preferential issue plan approved in 2026. The next set of disclosures investors will watch are updates on further allotments under the remaining warrant approvals and any conversion activity within the 18-month window.